Literature DB >> 14986165

Fatal Microascus trigonosporus (anamorph Scopulariopsis) pneumonia in a bone marrow transplant recipient.

I Mohammedi1, M A Piens, C Audigier-Valette, J C Gantier, L Argaud, O Martin, D Robert.   

Abstract

Over the past decade, an increasing number of opportunistic mycelial fungal infections have been reported in immunocompromised patients. Presented here is the first reported case of Microascus trigonosporus pneumonia, which occurred in a 24-year-old-man with a history of allogenic bone marrow transplantation with graft-versus-host disease. Despite the administration of effective antifungal treatment, the patient died after uncontrollable respiratory failure and multiorgan failure developed. This report confirms the results of previous studies that suggested a very poor outcome for bone marrow transplant recipients with non-Aspergillus mould infections.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14986165     DOI: 10.1007/s10096-003-1096-y

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  12 in total

1.  Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients.

Authors:  E Jantunen; P Ruutu; L Niskanen; L Volin; T Parkkali; P Koukila-Kähkölä; T Ruutu
Journal:  Bone Marrow Transplant       Date:  1997-04       Impact factor: 5.483

2.  Deep-seated mycosis as a complication in bone marrow transplantation patients.

Authors:  M Wakayama; K Shibuya; T Ando; T Oharaseki; K Takahashi; S Naoe; W F Coulson
Journal:  Mycoses       Date:  2002-06       Impact factor: 4.377

3.  Invasive mold infections in allogeneic bone marrow transplant recipients.

Authors:  J W Baddley; T P Stroud; D Salzman; P G Pappas
Journal:  Clin Infect Dis       Date:  2001-04-13       Impact factor: 9.079

4.  Invasive Scopulariopsis in the immunocompromised host.

Authors:  J P Neglia; D D Hurd; P Ferrieri; D C Snover
Journal:  Am J Med       Date:  1987-12       Impact factor: 4.965

5.  Microascus cinereus (Anamorph scopulariopsis) brain abscess in a bone marrow transplant recipient.

Authors:  J W Baddley; S A Moser; D A Sutton; P G Pappas
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

Review 6.  Therapeutic outcome in invasive aspergillosis.

Authors:  D W Denning
Journal:  Clin Infect Dis       Date:  1996-09       Impact factor: 9.079

Review 7.  Bone marrow transplantation.

Authors:  J O Armitage
Journal:  N Engl J Med       Date:  1994-03-24       Impact factor: 91.245

8.  Pathogenic fungi in soils of Jabalpur, India.

Authors:  A Pandey; G P Agrawal; S M Singh
Journal:  Mycoses       Date:  1990-03       Impact factor: 4.377

9.  Disseminated Microascus cirrosus infection in pediatric bone marrow transplant recipient.

Authors:  K K Krisher; N B Holdridge; M M Mustafa; M G Rinaldi; D A McGough
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

10.  Suppurative cutaneous granulomata caused by Microascus cinereus in a patient with chronic granulomatous disease.

Authors:  A R Marques; K J Kwon-Chung; S M Holland; M L Turner; J I Gallin
Journal:  Clin Infect Dis       Date:  1995-01       Impact factor: 9.079

View more
  9 in total

1.  Scopulariopsis, a poorly known opportunistic fungus: spectrum of species in clinical samples and in vitro responses to antifungal drugs.

Authors:  Marcelo Sandoval-Denis; Deanna A Sutton; Annette W Fothergill; Josep Cano-Lira; Josepa Gené; C A Decock; G S de Hoog; Josep Guarro
Journal:  J Clin Microbiol       Date:  2013-09-11       Impact factor: 5.948

2.  In vitro activities of 10 combinations of antifungal agents against the multiresistant pathogen Scopulariopsis brevicaulis.

Authors:  Manuel Cuenca-Estrella; Alicia Gomez-Lopez; Maria J Buitrago; Emilia Mellado; Guillermo Garcia-Effron; Juan L Rodriguez-Tudela
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

3.  Histone deacetylase inhibitors as a tool to up-regulate new fungal biosynthetic products: isolation of EGM-556, a cyclodepsipeptide, from Microascus sp.

Authors:  Hélène C Vervoort; Marija Drašković; Phillip Crews
Journal:  Org Lett       Date:  2010-12-21       Impact factor: 6.005

4.  Resistant Microascus cirrosus pneumonia can be treated with a combination of surgery, multiple anti-fungal agents and a growth factor.

Authors:  Celalettin Ustun; Gerwin Huls; Marc Stewart; Kieren A Marr
Journal:  Mycopathologia       Date:  2006-10       Impact factor: 2.574

Review 5.  Melanized fungi in human disease.

Authors:  Sanjay G Revankar; Deanna A Sutton
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

6.  Redefining Microascus, Scopulariopsis and allied genera.

Authors:  M Sandoval-Denis; J Gené; D A Sutton; J F Cano-Lira; G S de Hoog; C A Decock; N P Wiederhold; J Guarro
Journal:  Persoonia       Date:  2015-04-15       Impact factor: 11.051

7.  Tracking the emerging human pathogen Pseudallescheria boydii by using highly specific monoclonal antibodies.

Authors:  Christopher R Thornton
Journal:  Clin Vaccine Immunol       Date:  2009-03-25

8.  Invasive Microascus trigonosporus Species Complex Pulmonary Infection in a Lung Transplant Recipient.

Authors:  Kelly E Schoeppler; Martin R Zamora; Noelle M Northcutt; Gerard R Barber; Gayle O'Malley-Schroeder; Dennis M Lyu
Journal:  Case Rep Transplant       Date:  2015-05-14

9.  Rapid Assays for Specific Detection of Fungi of Scopulariopsis and Microascus Genera and Scopulariopsis brevicaulis Species.

Authors:  Milena Kordalewska; Tomasz Jagielski; Anna Brillowska-Dąbrowska
Journal:  Mycopathologia       Date:  2016-06-02       Impact factor: 2.574

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.